Home » India’s New Guideline on Patents Should Spur R&D
India’s New Guideline on Patents Should Spur R&D
India’s final guideline on drug patent applications drops a proposed clause that would have required manufacturers to list names of similar generic products in their filings.
Generic Line
Upcoming Events
-
11Jul
-
18Jul
-
21Oct